Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    30607
Show Display Options
Rank Status Study
1 Completed Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Conditions: Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sunitinib Malate
2 Active, not recruiting Collection of Patient-Reported Symptoms and Performance Status Via the Internet
Conditions: Prostate Cancer;   Breast Cancer;   Lung Cancer;   Colorectal Cancer;   Leukemia;   Multiple Myeloma
Interventions: Other: internet-based intervention;   Other: assessment of therapy complications;   Other: Questionnaire Administration
3 Completed
Has Results
Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
Condition: Hypertension

Indicates status has not been verified in more than two years